Kyra Zodel

ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma

P. Seidel, M. Boerries, D. von Elverfeldt, 2022, JCI insight.

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition

P. Seidel, P. Wild, T. Brummer, 2021, Cancers.

MARVEL domain containing CMTM4 affects CXCR4 trafficking

M. Seifert, G. Walz, W. Römer, 2022, Molecular biology of the cell.

Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma

P. Seidel, A. Köttgen, M. Boerries, 2021, Cancers.

Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma

E. Neumann-Haefelin, Athina Ganner, D. Plattner, 2023, Cells.

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia

M. Lübbert, R. Zeiser, J. Duque-Afonso, 2023, Cancers.